Abstract
The glioblastoma (GBM) is an extremely lethal brain tumor in adults for which there is no effective therapy. Many factors contribute to its aggressiveness, namely the high cellular and molecular heterogeneity and the presence of glioblastoma stem-cells (GSCs), crucial for the treatment resistance and tumor recurrence. Several evidence shows that the gene expression of the cellular prion p…